Administration of docetaxel in a weekly schedule may offer similar efficacy, with a more favorable toxicity profile, compared to a three-weekly schedule in patients with breast cancer. 
This presentation will revisit Docetaxel schedule in early breast cancer & metastatic breast cancer.